FONAR Corporation (FONR)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 2,025,000 24,950,000 24,960,000 25,943,089
Cost of Revenue 4,901,000 15,212,000 14,917,000 15,348,044
Gross Profit -2,876,000 9,738,000 10,043,000 10,595,045
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 7,991,000 6,927,000 5,130,000 8,822,732
Operating Expenses 18,602,000 7,303,000 5,437,000 9,261,681
Operating Income 3,662,000 2,435,000 4,606,000 1,333,364
Interest Expense -7,000 6,000 8,000 9,997
Income Before Tax 4,130,000 2,967,000 5,249,000 1,919,385
Income Tax Expense -1,006,000 762,000 1,249,000 284,968
Net Income 5,136,000 1,964,000 3,135,000 830,396
Per Share
EPS 0.11 0.29 0.47 0.12
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 104,351,318 102,884,089 98,645,101 97,592,145 89,929,765
Cost of Revenue 19,130,935 57,744,044 52,897,158 50,578,201 46,456,127
Gross Profit 85,220,383 45,140,045 45,747,943 47,013,944 43,473,638
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 29,734,163 26,868,732 29,390,932 23,512,581 24,740,044
Operating Expenses 73,621,626 28,604,681 30,958,681 25,006,762 26,376,023
Operating Income 11,598,757 16,535,364 14,789,262 22,007,182 17,097,615
Interest Expense 25,611 76,997 50,131 346,552 248,665
Income Before Tax 13,780,238 19,266,385 15,758,587 22,768,875 17,665,331
Income Tax Expense 3,106,805 5,168,968 3,632,071 5,534,487 3,991,520
Net Income 8,334,261 10,567,396 9,375,776 17,234,388 10,207,588
Per Share
EPS 1.21 1.49 1.35 2.59 1.47
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-12-31
Assets
Cash and Cash Equivalents 56,333,636 56,341,193 51,279,707 49,505,000
Short Term Investments 120,494 136,102 32,799 32,000
Net Receivables 82,944,279 79,845,587 70,170,897 3,949,000
Inventory 2,812,682 2,715,441 2,569,666 2,634,000
Total Current Assets 144,671,810 140,324,285 125,660,837 120,749,000
Property Plant Equipment 54,044,900 57,667,025 55,944,357 56,563,000
Goodwill and Intangibles 7,261,480 7,139,601 7,701,142 7,846,000
Total Assets 216,907,877 214,245,969 200,581,887 197,498,000
Liabilities
Account Payables 1,302,317 1,855,879 1,579,240 866,000
Short Term Debt 3,630,538,912 3,746,460 4,166,848 4,208,000
Total Current Liabilities 17,124,406 17,857,080 15,624,373 13,745,000
Long Term Debt 35,326,721,430 37,929,407 32,840,961 34,004,000
Total Liabilities 56,803,257 57,457,580 49,754,747 49,428,000
Shareholders Equity
Retained Earnings -5,289,324 -13,623,585 -24,190,981 0
Total Shareholders Equity 172,608,186 165,967,997 157,906,433 148,070,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-09-30
Assets
Cash and Cash Equivalents 56,333,636 56,341,193 51,279,707 49,505,000 48,696,000
Short Term Investments 120,494 136,102 32,799 32,000 32,000
Net Receivables 82,944,279 79,845,587 70,170,897 3,949,000 4,161,000
Inventory 2,812,682 2,715,441 2,569,666 2,634,000 2,458,000
Total Current Assets 144,671,810 140,324,285 125,660,837 120,749,000 119,066,000
Property Plant Equipment 54,044,900 57,667,025 55,944,357 56,563,000 57,265,000
Goodwill and Intangibles 7,261,480 7,139,601 7,701,142 7,846,000 7,893,000
Total Assets 216,907,877 214,245,969 200,581,887 197,498,000 198,022,000
Liabilities
Account Payables 1,302,317 1,855,879 1,579,240 866,000 773,000
Short Term Debt 3,630,538,912 3,746,460 4,166,848 4,208,000 4,162,000
Total Current Liabilities 17,124,406 17,857,080 15,624,373 13,745,000 14,873,000
Long Term Debt 35,326,721,430 37,929,407 32,840,961 34,004,000 34,044,000
Total Liabilities 56,803,257 57,457,580 49,754,747 49,428,000 50,892,000
Shareholders Equity
Retained Earnings -5,289,324 -13,623,585 -24,190,981 0 0
Total Shareholders Equity 172,608,186 165,967,997 157,906,433 148,070,000 147,130,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income 10,673,433 10,567,396 12,126,516 17,234,388
Depreciation & Amortization 4,698,321 8,908,183 8,804,953 8,535,367
Stock Based Compensation 0 0 0 0
Change in Working Capital -7,549,713 -12,941,130 -15,170,609 -14,205,057
Operating Cash Flow 2,025,000 14,093,294 14,467,130 15,301,360
Investing Activities
Capital Expenditure -3,791,581 -822,846 -4,337,655 -4,633,174
Investments -3,791,581 -789,961 -4,337,655 -4,633,174
Investing Cash Flow -3,801,298 -850,738 -4,338,128 -5,179,323
Financing Activities
Debt Repayment -113,940 -44,902 -36,615 -37,239
Common Stock Issued/Repurchased -1,806,646 -2,505,832 -1,759,457 0
Dividends Paid 0 0 0 0
Financing Cash Flow -7,471,141 -8,181,070 -7,572,272 -5,859,471
Summary
Free Cash Flow 7,473,301 13,270,448 10,129,475 10,668,186
Net Change in Cash -7,557 5,061,486 2,556,730 4,262,566
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income 10,673,433 10,567,396 12,126,516 17,234,388 13,673,811
Depreciation & Amortization 4,698,321 8,908,183 8,804,953 8,535,367 5,539,740
Stock Based Compensation 0 0 0 0 83,277
Change in Working Capital -7,549,713 -12,941,130 -15,170,609 -14,205,057 -11,262,362
Operating Cash Flow 2,025,000 14,093,294 14,467,130 15,301,360 19,088,001
Investing Activities
Capital Expenditure -3,791,581 -822,846 -4,337,655 -4,633,174 -4,819,304
Investments -3,791,581 -789,961 -4,337,655 -4,633,174 -4,655,599
Investing Cash Flow -3,801,298 -850,738 -4,338,128 -5,179,323 -4,819,597
Financing Activities
Debt Repayment -113,940 -44,902 -36,615 -37,239 -103,335
Common Stock Issued/Repurchased -1,806,646 -2,505,832 -1,759,457 0 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow -7,471,141 -8,181,070 -7,572,272 -5,859,471 -6,610,335
Summary
Free Cash Flow 7,473,301 13,270,448 10,129,475 10,668,186 14,268,697
Net Change in Cash -7,557 5,061,486 2,556,730 4,262,566 7,658,069